Author

Robert A. Medve

Observed names: R A Medve, R. Medve, Robert A Medve, Robert Medve

Institution: Nektar Therapeutics (United States)

Observed institutions: Translational Genomics Research Institute, Johnson & Johnson (United States), Children's Hospital of Philadelphia, Norton Healthcare, Nektar Therapeutics (United States), Mayo Clinic Hospital, Rocky Mountain Cancer Centers, University of Pennsylvania

OpenAlex ID: A5059831706

Tramadol and acetaminophen tablets for dental pain.

2001 · R A Medve, J Wang, et al. · PubMed · 108

An Evaluation of the Efficacy and Tolerability of Oral Tramadol Hydrochloride Tablets for the Treatment of Postsurgical Pain in Children

2002 · Julia C. Finkel, John B. Rose, et al. · Anesthesia & Analgesia · 77

Oral Tramadol for the Treatment of Pain of 7–30 Days’ Duration in Children

2003 · John B. Rose, Julia C. Finkel, et al. · Anesthesia & Analgesia · 67

Opioid formulations in development designed to curtail abuse: who is the target?

2009 · Lynn R Webster, Brad Bath, et al. · Expert Opinion on Investigational Drugs · 57

Concordance between Tramadol and Dextromethorphan Parent/Metabolite Ratios: The Influence of CYP2D6 and Non‐CYP2D6 Pathways on Biotransformation

2002 · S. M. Abdel‐Rahman, J. S. Leeder, et al. · The Journal of Clinical Pharmacology · 56

A Multicenter, Phase I, Dose-Escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of Etirinotecan Pegol in Patients with Refractory Solid Tumors

2012 · Gayle S. Jameson, John T. Hamm, et al. · Clinical Cancer Research · 55

Randomized, Double-Blind, Placebo-Controlled Study of the Abuse Potential of Different Formulations of Oral Oxycodone

2012 · Lynn R. Webster, Brad Bath, et al. · Pain Medicine · 49

An enhanced bunionectomy model as a potential tool for early decision-making in the development of new analgesics

2010 · Hao Wang, Cynthia Gargano, et al. · Advances in Therapy · 26

Safety, tolerability, pharmacokinetics, and pharmacodynamic effects of naloxegol at peripheral and central nervous system receptors in healthy male subjects: A single ascending‐dose study

2015 · Michael A. Eldon, Alan R. Kugler, et al. · Clinical Pharmacology in Drug Development · 21

Safety and pharmacokinetics of NXN-188 after single and multiple doses in five phase I, randomized, double-blind, parallel studies in healthy adult volunteers

2010 · David Vaughan, Joanne Speed, et al. · Clinical Therapeutics · 20

Safety, tolerability, and pharmacokinetics of multiple ascending doses of naloxegol

2015 · Michael A. Eldon, Alan R. Kugler, et al. · Clinical Pharmacology in Drug Development · 11

Abuse potential assessment of novel opioid analgesic NKTR-181: Implications for labeling and scheduling

2014 · Lynn R. Webster, S. Smith, et al. · Drug and Alcohol Dependence · 2

Works count: 13

Citation count: 549

H-index: 11

I10-index: 11